Form 4 for ARCT Arcturus Therapeutics Holdings Inc.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001193805-22-001207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | 2022-08-15 | ARCT | SASSINE ANDY | CFO, Dir | A - Grant | $18.42 | +1,068 | 269.3K | +0.4% | +$19.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | A | A | 1,068 | $18.42 | 269,303 | D | — | — | (F1) Represents shares of common stock purchased by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP"). (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2022. |